Next Article in Journal
In Vitro Evaluation and Mitigation of Niclosamide’s Liabilities as a COVID-19 Treatment
Next Article in Special Issue
Adverse Reactions after the Third Dose of the BNT162b2 mRNA COVID-19 Vaccine among Medical School Residents in a Regional Reference University Hospital in Italy
Previous Article in Journal
Factors Contributing to SARS-CoV-2 Vaccine Hesitancy of Hispanic Population in Rio Grande Valley
Previous Article in Special Issue
Increased Mild Vaccine-Related Side Effects and Higher Specific Antibody Titers in Health Care Workers with Previous SARS-CoV-2 Infection after the mRNA BNT162b2 Vaccine
 
 
Article

Article Versions Notes

Vaccines 2022, 10(8), 1283; https://doi.org/10.3390/vaccines10081283
Action Date Notes Link
article xml file uploaded 9 August 2022 11:39 CEST Original file -
article xml uploaded. 9 August 2022 11:39 CEST Update -
article pdf uploaded. 9 August 2022 11:39 CEST Version of Record -
article html file updated 9 August 2022 11:41 CEST Original file -
article xml file uploaded 9 August 2022 12:37 CEST Update -
article xml uploaded. 9 August 2022 12:37 CEST Update -
article pdf uploaded. 9 August 2022 12:37 CEST Updated version of record -
article html file updated 9 August 2022 12:38 CEST Update -
article xml file uploaded 9 August 2022 12:43 CEST Update -
article xml uploaded. 9 August 2022 12:43 CEST Update https://www.mdpi.com/2076-393X/10/8/1283/xml
article pdf uploaded. 9 August 2022 12:43 CEST Updated version of record https://www.mdpi.com/2076-393X/10/8/1283/pdf
article html file updated 9 August 2022 12:45 CEST Update https://www.mdpi.com/2076-393X/10/8/1283/html
Back to TopTop